Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

442 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Humic substances mediated superior photochemical pollutant conversion on defective TiO2 in environmentally relevant matrices: The key roles of oxygen vacancy in surface interactions, oxidant activation and radical generation.
Hu S, Ye L, Tian BJ, Li JY, Zhang AY, Zhao L, Zhang C, Jiang C, Lin ZX, Da W, Wei QX. Hu S, et al. Among authors: lin zx. Sci Total Environ. 2024 Apr 15;921:171145. doi: 10.1016/j.scitotenv.2024.171145. Epub 2024 Feb 21. Sci Total Environ. 2024. PMID: 38395167
Assessing the efficacy and safety of Yinqiao powder-maxing Ganshi decoction in the treatment of the major symptoms of mild and moderate COVID-19 by telemedicine-study protocol for a randomized, double-blind, placebo-controlled trial.
Sum CH, Li TW, Zhang H, Hung HY, Fong BYF, Lin WL, Chow TY, Leung KC, Lo CW, Chia CP, Chan KL, Lin ZX. Sum CH, et al. Among authors: lin zx. Front Pharmacol. 2024 Jan 8;14:1261338. doi: 10.3389/fphar.2023.1261338. eCollection 2023. Front Pharmacol. 2024. PMID: 38259270 Free PMC article.
Corrigendum: A Chinese medicine formula (Bushen Huoxue Tongluo) for the treatment of chronic subjective tinnitus: a study protocol for a pilot, assessor-blinded, randomized clinical trial.
Zhang HW, Yeung KNK, Tong MCF, Lin ZX, Chang WWT, Ng IH, Sum CH, Leung KC, Chan KL, Ngan K, Tong TJ. Zhang HW, et al. Among authors: lin zx. Front Pharmacol. 2023 Sep 7;14:1258855. doi: 10.3389/fphar.2023.1258855. eCollection 2023. Front Pharmacol. 2023. PMID: 37745086 Free PMC article.
Antiviral efficacy of RAY1216 monotherapy and combination therapy with ritonavir in patients with COVID-19: a phase 2, single centre, randomised, double-blind, placebo-controlled trial.
Wang B, Li HJ, Cai MM, Lin ZX, Ou XF, Wu SH, Cai RH, Wei YN, Yang F, Zhu YM, Yang ZF, Zhong NS, Lin L. Wang B, et al. Among authors: lin zx, lin l. EClinicalMedicine. 2023 Aug 31;63:102189. doi: 10.1016/j.eclinm.2023.102189. eCollection 2023 Sep. EClinicalMedicine. 2023. PMID: 37692076 Free PMC article.
Autophagy Regulators in Cancer.
Zhang J, Xiang Q, Wu M, Lao YZ, Xian YF, Xu HX, Lin ZX. Zhang J, et al. Among authors: lin zx. Int J Mol Sci. 2023 Jun 30;24(13):10944. doi: 10.3390/ijms241310944. Int J Mol Sci. 2023. PMID: 37446120 Free PMC article. Review.
Intramural Esophageal Hematoma With Associated Hemothorax.
Lin ZX, Weiss A, Li B, Pais S. Lin ZX, et al. ACG Case Rep J. 2023 Jan 13;10(1):e00957. doi: 10.14309/crj.0000000000000957. eCollection 2023 Jan. ACG Case Rep J. 2023. PMID: 36699187 Free PMC article.
The efficacy and safety of Yupingfeng Powder with variation in the treatment of allergic rhinitis: Study protocol for a randomized, double-blind, placebo-controlled trial.
Cheong PK, Ho TM, Chan KL, Lo CW, Leung SB, Hon KL, Leung KC, Siu THC, Song TH, Zhang H, Ching JYL, Chow TY, Sum CH, Chia CP, Lin ZX. Cheong PK, et al. Among authors: lin zx. Front Pharmacol. 2022 Dec 16;13:1058176. doi: 10.3389/fphar.2022.1058176. eCollection 2022. Front Pharmacol. 2022. PMID: 36588672 Free PMC article.
Correction: Effects of Chinese medicine for COVID-19 rehabilitation: a multicenter observational study.
Zhong LL, Wong YP, Leung CY, Peng B, Lin ZX, Taam VCW, Luo Y, Chen HY, Chao CD, Wong CF, Tam FS, Chan K, Lee KY, Ho LF, Wong AY, Choy CF, Ng BF, Wong RH, Feng YB, Liong C, Bian ZX; COVID-19 CM Research Working Group. Zhong LL, et al. Among authors: lin zx. Chin Med. 2022 Oct 24;17(1):120. doi: 10.1186/s13020-022-00674-9. Chin Med. 2022. PMID: 36280844 Free PMC article. No abstract available.
Effects of Chinese medicine for COVID-19 rehabilitation: a multicenter observational study.
Zhong LL, Wong YP, Leung CY, Peng B, Lin ZX, Wong Taam VC, Luo Y, Chen HY, Chao CD, Wong CF, Tam FS, Chan K, Lee KY, Ho LF, Wong AY, Choy CF, Ng BF, Wong RH, Feng YB, Liong C, Bian ZX; COVID-19 CM Research Working Group. Zhong LL, et al. Among authors: lin zx. Chin Med. 2022 Aug 22;17(1):99. doi: 10.1186/s13020-022-00654-z. Chin Med. 2022. PMID: 35996191 Free PMC article.
A Chinese Medicine Formula (Bushen Huoxue Tongluo) for the Treatment of Chronic Subjective Tinnitus: A Study Protocol for a Pilot, Assessor-Blinded, Randomized Clinical Trial.
Zhang HW, Yeung KNK, Tong MCF, Lin ZX, Chang WWT, Ng IH, Sum CH, Leung KC, Chan KL, Ngan K, Tong TJ. Zhang HW, et al. Among authors: lin zx. Front Pharmacol. 2022 Mar 30;13:844730. doi: 10.3389/fphar.2022.844730. eCollection 2022. Front Pharmacol. 2022. PMID: 35431960 Free PMC article.
Brusatol suppresses STAT3-driven metastasis by downregulating epithelial-mesenchymal transition in hepatocellular carcinoma.
Lee JH, Mohan CD, Deivasigamani A, Jung YY, Rangappa S, Basappa S, Chinnathambi A, Alahmadi TA, Alharbi SA, Garg M, Lin ZX, Rangappa KS, Sethi G, Hui KM, Ahn KS. Lee JH, et al. Among authors: lin zx. J Adv Res. 2020 Jul 13;26:83-94. doi: 10.1016/j.jare.2020.07.004. eCollection 2020 Nov. J Adv Res. 2020. PMID: 33133685 Free PMC article.
Bismuth chelate as a contrast agent for X-ray computed tomography.
Fu JJ, Guo JJ, Qin AP, Yu XY, Zhang Q, Lei XP, Huang YG, Chen MY, Li JX, Zhang Y, Liu JP, Dang YY, Wu D, Zhao XY, Lin ZX, Lin YL, Li SP, Zhang LY. Fu JJ, et al. Among authors: lin yl, lin zx. J Nanobiotechnology. 2020 Aug 6;18(1):110. doi: 10.1186/s12951-020-00669-4. J Nanobiotechnology. 2020. PMID: 32762751 Free PMC article.
Acupuncture for Poststroke Dysphagia: A Pilot, Nonrandomized, Self-Controlled Trial.
Chan YT, Zhang HW, Sun WZ, Hang Or KK, Guo YQ, Chen M, Wu GY, Xu GY, Leung C, Tam S, Chun-Keung Mok F, Kwan YK, Chow E, Wo Mak JK, Chun-Kwok Chu A, Lee K, Law T, Ming Wong RW, Lin ZX. Chan YT, et al. Among authors: lin zx. Evid Based Complement Alternat Med. 2020 May 11;2020:4689296. doi: 10.1155/2020/4689296. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32454860 Free PMC article.
[Analysis of anti-fatigue mechanism and potential targets of ginseng].
Liu FX, Lin ZX, Zhang HL, Zhang ZQ, Yang KQ, Fan XF, Xu J, Wang YT, Zhao YN. Liu FX, et al. Among authors: lin zx. Zhongguo Zhong Yao Za Zhi. 2019 Dec;44(24):5479-5487. doi: 10.19540/j.cnki.cjcmm.20190805.401. Zhongguo Zhong Yao Za Zhi. 2019. PMID: 32237398 Chinese.
Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
Li HQ, Ip SP, Yuan QJ, Zheng GQ, Tsim KKW, Dong TTX, Lin G, Han Y, Liu Y, Xian YF, Lin ZX. Li HQ, et al. Among authors: lin zx, lin g. Brain Behav Immun. 2019 Nov;82:264-278. doi: 10.1016/j.bbi.2019.08.194. Epub 2019 Aug 30. Brain Behav Immun. 2019. PMID: 31476414
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial.
Yang Q, Cao SM, Guo L, Hua YJ, Huang PY, Zhang XL, Lin M, You R, Zou X, Liu YP, Xie YL, Wang ZQ, Mai HQ, Chen QY, Tang LQ, Mo HY, Cao KJ, Qian CN, Zhao C, Xiang YQ, Zhang XP, Lin ZX, Li WX, Liu Q, Li JB, Ling L, Guo X, Hong MH, Chen MY. Yang Q, et al. Among authors: lin zx, lin m. Eur J Cancer. 2019 Sep;119:87-96. doi: 10.1016/j.ejca.2019.07.007. Epub 2019 Aug 16. Eur J Cancer. 2019. PMID: 31425966 Clinical Trial.
Overexpression of long noncoding RNA LINC01419 in esophageal squamous cell carcinoma and its relation to the sensitivity to 5-fluorouracil by mediating GSTP1 methylation.
Chen JL, Lin ZX, Qin YS, She YQ, Chen Y, Chen C, Qiu GD, Zheng JT, Chen ZL, Zhang SY. Chen JL, et al. Among authors: lin zx. Ther Adv Med Oncol. 2019 Apr 12;11:1758835919838958. doi: 10.1177/1758835919838958. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31019568 Free PMC article.
Evidence on Integrating Pharmacokinetics to Find Truly Therapeutic Agent for Alzheimer's Disease: Comparative Pharmacokinetics and Disposition Kinetics Profiles of Stereoisomers Isorhynchophylline and Rhynchophylline in Rats.
Zhang C, Wu X, Xian Y, Zhu L, Lin G, Lin ZX. Zhang C, et al. Among authors: lin zx, lin g. Evid Based Complement Alternat Med. 2019 Feb 3;2019:4016323. doi: 10.1155/2019/4016323. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 30854007 Free PMC article.
Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer.
Evans JP, Winiarski BK, Sutton PA, Jones RP, Ressel L, Duckworth CA, Pritchard DM, Lin ZX, Fretwell VL, Tweedle EM, Costello E, Goldring CE, Copple IM, Park BK, Palmer DH, Kitteringham NR. Evans JP, et al. Among authors: lin zx. Oncotarget. 2019 Jan 18;10(6):685. doi: 10.18632/oncotarget.26625. eCollection 2019 Jan 18. Oncotarget. 2019. PMID: 30774766 Free PMC article.
Ameliorative effect of supercritical fluid extract of Chrysanthemum indicum Linnén against D-galactose induced brain and liver injury in senescent mice via suppression of oxidative stress, inflammation and apoptosis.
Zhang X, Wu JZ, Lin ZX, Yuan QJ, Li YC, Liang JL, Zhan JY, Xie YL, Su ZR, Liu YH. Zhang X, et al. Among authors: lin zx. J Ethnopharmacol. 2019 Apr 24;234:44-56. doi: 10.1016/j.jep.2018.12.050. Epub 2019 Jan 2. J Ethnopharmacol. 2019. PMID: 30610932
Corrigendum to "The Therapeutic Effects of a Traditional Chinese Medicine Formula Wuzi Yanzong Pill for the Treatment of Oligoasthenozoospermia: A Meta-Analysis of Randomized Controlled Trials".
Zhao MP, Shi X, Kong GWS, Wang CC, Wu JCY, Lin ZX, Li TC, Chan DYL. Zhao MP, et al. Among authors: lin zx. Evid Based Complement Alternat Med. 2018 Jun 21;2018:6109104. doi: 10.1155/2018/6109104. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 30034499 Free PMC article.
The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer.
Evans JP, Winiarski BK, Sutton PA, Jones RP, Ressel L, Duckworth CA, Pritchard DM, Lin ZX, Fretwell VL, Tweedle EM, Costello E, Goldring CE, Copple IM, Park BK, Palmer DH, Kitteringham NR. Evans JP, et al. Among authors: lin zx. Oncotarget. 2018 Jun 5;9(43):27104-27116. doi: 10.18632/oncotarget.25497. eCollection 2018 Jun 5. Oncotarget. 2018. PMID: 29930754 Free PMC article.
The Therapeutic Effects of a Traditional Chinese Medicine Formula Wuzi Yanzong Pill for the Treatment of Oligoasthenozoospermia: A Meta-Analysis of Randomized Controlled Trials.
Zhao MP, Shi X, Kong GWS, Wang CC, Wu JCY, Lin ZX, Li TC, Chan DYL. Zhao MP, et al. Among authors: lin zx. Evid Based Complement Alternat Med. 2018 Jan 17;2018:2968025. doi: 10.1155/2018/2968025. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 29576794 Free PMC article. Review.
Comparison of five staging systems in predicting the survival rate of patients with hepatocellular carcinoma undergoing trans-arterial chemoembolization therapy.
Chen ZH, Hong YF, Chen X, Chen J, Lin Q, Lin J, Li X, Wen JY, Ruan DY, Dong M, Wei L, Wang TT, Lin ZX, Ma XK, Wu DH, Wu XY, Xu R. Chen ZH, et al. Among authors: lin q, lin j, lin zx. Oncol Lett. 2018 Jan;15(1):855-862. doi: 10.3892/ol.2017.7419. Epub 2017 Nov 15. Oncol Lett. 2018. PMID: 29403561 Free PMC article.
Improving the prediction of overall survival for head and neck cancer patients using image biomarkers in combination with clinical parameters.
Zhai TT, van Dijk LV, Huang BT, Lin ZX, Ribeiro CO, Brouwer CL, Oosting SF, Halmos GB, Witjes MJH, Langendijk JA, Steenbakkers RJHM, Sijtsema NM. Zhai TT, et al. Among authors: lin zx. Radiother Oncol. 2017 Aug;124(2):256-262. doi: 10.1016/j.radonc.2017.07.013. Epub 2017 Jul 29. Radiother Oncol. 2017. PMID: 28764926 Free article.
Validation and ranking of seven staging systems of hepatocellular carcinoma.
Chen ZH, Hong YF, Lin J, Li X, Wu DH, Wen JY, Chen J, Ruan DY, Lin Q, Dong M, Wei L, Wang TT, Lin ZX, Ma XK, Wu XY, Xu R. Chen ZH, et al. Among authors: lin q, lin j, lin zx. Oncol Lett. 2017 Jul;14(1):705-714. doi: 10.3892/ol.2017.6222. Epub 2017 May 22. Oncol Lett. 2017. PMID: 28693224 Free PMC article.
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial.
Cao SM, Yang Q, Guo L, Mai HQ, Mo HY, Cao KJ, Qian CN, Zhao C, Xiang YQ, Zhang XP, Lin ZX, Li WX, Liu Q, Qiu F, Sun R, Chen QY, Huang PY, Luo DH, Hua YJ, Wu YS, Lv X, Wang L, Xia WX, Tang LQ, Ye YF, Chen MY, Guo X, Hong MH. Cao SM, et al. Among authors: lin zx. Eur J Cancer. 2017 Apr;75:14-23. doi: 10.1016/j.ejca.2016.12.039. Epub 2017 Feb 16. Eur J Cancer. 2017. PMID: 28214653 Clinical Trial.
Antidepressant-Like Effect of Isorhynchophylline in Mice.
Xian YF, Fan D, Ip SP, Mao QQ, Lin ZX. Xian YF, et al. Among authors: lin zx. Neurochem Res. 2017 Feb;42(2):678-685. doi: 10.1007/s11064-016-2124-5. Epub 2016 Nov 30. Neurochem Res. 2017. PMID: 27900600
Effects of omitting elective neck irradiation to nodal Level IB in nasopharyngeal carcinoma patients with negative Level IB lymph nodes treated by intensity-modulated radiotherapy: a Phase 2 study.
Li M, Huang XG, Yang ZN, Lu JY, Zhan YZ, Xie WJ, Zhou DJ, Wang L, Zhu DX, Lin ZX. Li M, et al. Among authors: lin zx. Br J Radiol. 2016 Sep;89(1065):20150621. doi: 10.1259/bjr.20150621. Epub 2016 Jul 4. Br J Radiol. 2016. PMID: 27376590 Free PMC article. Clinical Trial.
442 results